Supplementary Figure 2 from BRAF Inhibitor Vemurafenib Improves the Antitumor Activity of Adoptive Cell Immunotherapy
crossref（2023）
摘要
PDF file - 190K, Flow cytometric analysis of H2-Db expression by SM1 with or without exposure to vemurafenib for different periods
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要